About Torrent Research Centre
Clinical Trials at Torrent Research Centre
During the past decade, Torrent Research Centre conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Torrent Research Centre
According to Clinical.Site data, the most researched conditions in "Torrent Research Centre" are
"Healthy" (3 trials) and "Type 2 Diabetes" (3 trials). Many other conditions were trialed in "Torrent Research Centre" in a lesser frequency.
Clinical Trials Intervention Types at Torrent Research Centre
Most popular intervention types in "Torrent Research Centre" are "Drug" (6 trials). Other intervention types were less common.
The name of intervention was led by "Metformin" (3 trials), "Losartan Potassium Tablets" (2 trials) and "Losartan Potassium and Hydrochlorothiazide Tablets" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Torrent Research Centre
The vast majority of trials in "Torrent Research Centre" are
5 trials for "Male" genders.
Clinical Trials Status at Torrent Research Centre
Currently, there are NaN active trials in "Torrent Research Centre".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in Torrent Research Centre,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Torrent Research Centre, 6 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".